Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study.
暂无分享,去创建一个
J. Maris | M. Lim | K. Wilner | C. Ahern | P. Adamson | F. Balis | Y. Mossé | S. Voss | J. Laliberté | B. Weigel | S. Blaney | K. Ruffner | A. Ingle | D. Rolland